The Risk of Quinolones in Hemodialysis

Fluoroquinolone antibiotics are widely prescribed in the US despite a growing number of serious adverse effects associated with their use. One of these adverse effects is QTc prolongation which can lead to lethal arrhythmias. A recent study evaluates in patients on hemodialysis are at an even higher risk.Redeem your CPE or CME credit here!Pharmacist membersCMENeed a membership?Join for CPE Credit Join for CME Credit References and resources: Assimon MM, Pun PH, Wang L, et al. Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis. JAMA Cardiol. Published online October 20, 2021. doi:10.1001/jamacardio.2021.4234Continuing Education Information:Learning Objectives: Describe the design and outcomes of a recent study that examines sudden cardiac death in a cohort of hemodialysis patients receiving quinolonesApply the results of this study to a specific patient case0.05 CEU | 0.5 HrsACPE UAN: 0107-0000-21-389-H01-PInitial release date: 12/06/21Expiration date: 12/06/21Additional CPE & CME details can be found hereFollow CEimpact on Social Media:LinkedInInstagram